Bringing a pharmaceutical product to market requires far more than generating strong scientific data. Companies must navigate complex regulatory requirements, coordinate documentation across multiple functions, meet strict submission timelines, respond to health authority questions, and maintain compliance after approval. Without the right regulatory oversight, even relatively small gaps can lead to incomplete submissions, additional authority questions, delayed approvals, and increased pressure on internal teams.

The challenge becomes even greater as products move through development, registration, and post-approval activities. Regulatory requirements must be interpreted correctly, documentation must remain consistent, and changes affecting quality, safety, efficacy, manufacturing, or Product Information must be assessed from a regulatory perspective. When responsibilities are fragmented or regulatory expertise is brought in too late, companies risk discovering critical issues when there is little room left to address them.This is where an experienced regulatory affairs specialist plays an important role.But what does a regulatory affairs specialist do in pharma, and why is this role so important throughout the medicinal product lifecycle? At Billev Pharma East, our regulatory affairs consulting services give pharmaceutical companies access to experienced regulatory affairs specialists who help interpret regulatory requirements, prepare the necessary documentation, and support regulatory activities throughout the product lifecycle.

How should companies integrate regulatory affairs expertise into pharmaceutical development?

Pharmaceutical companies should involve a regulatory affairs specialist early enough for regulatory requirements to be considered before important product decisions are made. The objective is not to develop regulatory activities separately from the rest of the organisation, but to ensure that regulatory implications are recognised throughout product development and beyond..

The timing and type of regulatory input may also depend on the organisation and development stage. Early-stage biotech companies, for example, may face different regulatory challenges at different development milestones.. For organisations operating in this environment, biotech regulatory consulting can provide more specialised support around these stage-specific regulatory needs.

This requires close coordination between Regulatory Affairs and the functions generating the scientific and technical information needed throughout the product lifecycle. CMC, Quality, Clinical, Pharmacovigilance, Medical, and other teams should understand when their activities may require regulatory input and when changes or new information should be assessed from a regulatory perspective.

Regulatory involvement should also continue after marketing authorisation. As an authorised medicinal product evolves, new information or product changes may create regulatory obligations that need to be identified and addressed appropriately.

Involving a regulatory affairs specialist at the relevant stages helps companies identify regulatory implications earlier and consider them when making scientific, technical, and operational decisions about the product.

How can Billev Pharma East regulatory affairs specialists support your product?

Understanding a regulatory requirement is only the first step. Companies also need the expertise to determine what that requirement means for their product and how it should be reflected in the relevant documentation and regulatory activities.At Billev Pharma East, our regulatory affairs specialists provide hands-on support across the medicinal product lifecycle. We can assist with the preparation and evaluation of regulatory documentation, marketing authorisation applications, CMC documentation, Product Information, variations, renewals, and communication with competent authorities. Where more specialised quality and manufacturing support is required, CMC consulting can help address the connection between CMC data, manufacturing processes, quality requirements, and regulatory expectations. Our team also supports National, Mutual Recognition, Decentralised, and Centralised Procedures according to the needs of the product and target market.

This practical involvement is particularly valuable when a regulatory activity requires input and coordination across several functions. Documentation may need input from different functions, changes may need regulatory assessment, and authority questions may require coordinated responses within defined timelines. EMA procedures themselves involve specific documentation, procedural requirements, contacts, and submission timelines, making effective regulatory coordination essential.

Billev Pharma East regulatory affairs specialists provide practical support for the regulatory activities related to your product, helping ensure that documentation, submissions, authority interactions, and post-authorisation requirements are handled in line with the applicable regulatory framework.

What does a regulatory affairs specialist do in pharma?

What does a regulatory affairs specialist do in pharma? A regulatory affairs specialist helps ensure that a medicinal product meets applicable regulatory requirements as it moves through development, registration, approval, and post-authorisation activities. The role ensures that regulatory requirements re considered alongside the scientific, technical, and operational work needed to bring a product to market and maintain it throughout its lifecycle.

In practice, this means interpreting regulatory requirements and determining what they mean for a specific product or activity. Depending on the stage of the product lifecycle, a specialist may be involved in preparing and reviewing regulatory documentation, coordinating regulatory submissions, maintaining registration dossiers, supporting Product Information, assessing the regulatory impact of product changes, and communicating with competent authorities. For electronic submissions, this work may also need to be coordinated with eCTD publishing activities to ensure that regulatory documentation is correctly prepared and submitted to the relevant authority.

A regulatory affairs specialist also works closely with other functions. Information generated by CMC, Quality, Clinical, Pharmacovigilance, Medical, and other teams may have regulatory implications, and Regulatory Affairs helps determine whether action is required and how that information should be reflected in the relevant regulatory documentation or procedure.

Importantly, the role does not end once marketing authorisation is granted. Authorised medicinal products continue to change, and those changes may require regulatory assessment and appropriate post-authorisation action. EMA maintains dedicated requirements and procedures covering both pre-authorisation activities and post-authorisation changes.

In this way, a regulatory affairs specialist helps companies understand not only what regulatory requirements apply, but what needs to be done to meet them throughout the medicinal product lifecycle.

When should a regulatory affairs specialist become involved?

A regulatory affairs specialist should become involved early enough to identify regulatory requirements that could affect product development or approval.t. Regulatory Affairs should therefore not be treated only as a function that prepares documentation immediately before submission.

During development, a regulatory affairs specialist can identify when scientific, technical, or operational activities have regulatory implications and ensure that these are considered before the product reaches critical regulatory milestones. As a product approaches registration, the specialist’s role becomes increasingly focused on ensuring that the required documentation and regulatory activities are ready for the relevant procedure. EMA’s pre-authorisation guidance demonstrates how preparation for a marketing authorisation application involves procedural planning and defined pre-submission activities before the application itself is filed.

Regulatory involvement remains important after approval because the authorised product continues to evolve. Manufacturing changes, updates to Product Information, new safety information, or other modifications may have regulatory consequences that need to be identified and managed appropriately. Effective lifecycle management services can support this ongoing work by helping ensure that regulatory changes and post-authorisation activities are managed consistently throughout the product lifecycle.

The earlier those implications are recognised, the easier it is for pharmaceutical companies to plan the required actions and avoid dealing with regulatory issues at a later stage.

Why is cross-functional collaboration important in Regulatory Affairs?

A regulatory affairs specialist works with regulatory requirements and the scientific, technical, and operational information generated across a pharmaceutical company.. Effective Regulatory Affairs therefore depends on close collaboration with the functions responsible for that information. This coordinating role can become particularly important when a regulatory affairs consultant is supporting a project that requires input from several internal scientific and technical functions.

CMC and Quality decisions may affect approved manufacturing or quality information, Clinical and Medical teams contribute evidence relevant to the product, Pharmacovigilance identifies safety information that may require regulatory action, and Product Information must remain aligned with the authorised medicinal product.

The regulatory affairs specialist helps identify when developments within these functions have regulatory implications and what action may be required. This requires the ability to understand specialist input, assess its regulatory relevance, and coordinate the information needed for the appropriate regulatory activity.

For pharmaceutical companies, this cross-functional role is particularly important because regulatory compliance is rarely the responsibility of Regulatory Affairs alone. The specialist coordinates regulatory input across teams, to ensure that important changes and decisions are considered from a regulatory perspective before they affect a submission or an authorised product.

Turn regulatory requirements into action with the right expertise

A regulatory affairs specialist provides the link between regulatory requirements and the practical work required to develop, register, and maintain a medicinal product. From recognising regulatory implications to supporting the documentation and activities required to address them, the role remains relevant throughout the product lifecycle.

At Billev Pharma East, our regulatory affairs specialists bring this expertise directly to pharmaceutical projects across EU and other markets wordlwide, supporting companies with the regulatory activities required for both new and authorised medicinal products.

Need a regulatory affairs specialist for your pharmaceutical project? Talk to Billev Pharma East about the regulatory support your product requires.

Sources: 1 -European Medicines Agency (EMA). (2026). Pre-authorisation guidance, 2 – European Medicines Agency (EMA). (2026). Guidance on the application of the revised variations framework, 3 – European Medicines Agency (EMA). (2026). Type-IB variations: questions and answers, 4 – European Medicines Agency (EMA). (2026). Type-II variations: questions and answers, 5 – International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH). (n.d.). M4: The Common Technical Document (CTD).